Toronto-based stem cell therapy firm attracts US$225M in funding — one of the largest ever for a biotech venture – Financial Post
Financial Post |
Toronto-based stem cell therapy firm attracts US$225M in funding — one of the largest ever for a biotech venture
Financial Post … Canada a go-to destination for the jobs of the future. Bains was in Toronto for the announcement of US$225 million in Series A funding for the Toronto-based medical stem cell company BlueRock Therapeutics, one of the largest ever for a biotech company. |
Nature World News |
Scientists Are Sending Stem Cells Into Space — Here’s Why
Nature World News A study on stem cell-derived heart cells aims to figure out if it would be possible to extend the stay of astronauts in space for longer periods of time and find out the anatomic effects of this microgravity environment. Since weightlessness can cause … |
FierceBiotech |
Bayer, Versant join forces on $225M Series A for stem cell upstart
FierceBiotech The startup, which is being hailed by the pair as a “next-generation regenerative medicine company” plans to develop best-in-class induced pluripotent stem cell (iPSC) therapies. Its initial focus will be on CNS and CV disease areas, the companies said … Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 …PR Newswire (press release) Bayer launches stem cell therapy company BlueRock TherapeuticsSeeking Alpha Bayer, Versant invest $225 million in biotech ventureReuters Channel NewsAsia all 4 news articles » |